Letter: optimising response to ustekinumab therapy for patients with Crohn’s disease—author's reply

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	907
Number of pages	1
Journal	Alimentary Pharmacology and Therapeutics
Volume	52
Issue number	5
DOIs	https://doi.org/10.1111/apt.15974
State	Published - 1 Sep 2020
Externally published	Yes

Access to Document

@article{2212edd7803b4a3fb33211e4dab0c40b,

title = "Letter: optimising response to ustekinumab therapy for patients with Crohn{\textquoteright}s disease—author's reply",

author = "Uri Kopylov",

year = "2020",

month = sep,

day = "1",

doi = "10.1111/apt.15974",

language = "אנגלית",

volume = "52",

pages = "907",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Letter

T2 - optimising response to ustekinumab therapy for patients with Crohn’s disease—author's reply

AU - Kopylov, Uri

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85089424148&partnerID=8YFLogxK

U2 - 10.1111/apt.15974

DO - 10.1111/apt.15974

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 32852835

AN - SCOPUS:85089424148

SN - 0269-2813

VL - 52

SP - 907

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 5

ER -